Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2490725A1 Devices and methodologies useful in body aesthetics
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490325A1 Transdermal aerosol compositions
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2490057A1 Metastable pharmaceutical compositions
12/31/2003CA2490043A1 8-(biaryl) quinoline pde4 inhibitors
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670380 Pyridone inhibitors of fatty acid binding protein and method
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2346001C Controlled release nanoparticulate compositions
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2269474C Method of alleviating pain by means of combining tramadol with an nmda antagonist
12/30/2003CA2144416C Method and composition for the treatment of hair loss
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/30/2003CA2080555C Bis(phenyl)ethane derivatives
12/25/2003WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236423 Trihydroxy polyunsaturated eicosanoids
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236405 7-hetero-bicyclo[2.2.1]-heptanes
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236303 Therapeutic compositions and methods of use
12/25/2003US20030236296 Novel interleukin-1beta converting enzyme inhibitors
12/25/2003US20030236289 Antiinflammatory agents; analgesics; antipyretics; cyclooxygenase inhibitor
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236249 Prevent binding to chemokines
12/25/2003US20030236245 Helix mimetics and composition and methods related thereto
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236235 Method and composition for potentiating the antipyretic action of a nonopioid analgesic
12/25/2003US20030236232 Novel spla2 inhibitors
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine
12/25/2003US20030235620 Animal extracts used as lipoxygenase inhibitors, antidiabetic, antiinflammatory, antiarthritic or antidiabetic agents; molluscs
12/25/2003US20030235610 Liposomes containing biologically active compounds
12/25/2003US20030235609 Use of cholinesterase antagonists to treat insulin resistance
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235572 Human GDP-mannose 4,6 dehydratase
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106503A1 O-sulphated bacterial polysaccharides and their use
12/24/2003WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a
12/24/2003WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003WO2003106460A1 Novel interleukin-1 beta converting enzyme inhibitors
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106441A1 Pharmaceutical salts of reboxetine
12/24/2003WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106426A1 Compounds, compositions, and methods
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106417A1 Mitotic kinesin inhibitors
12/24/2003WO2003106416A2 Chemical process
12/24/2003WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106381A2 Human adam-10 inhibitors
12/24/2003WO2003105900A1 Regulation of secretory phospholipase a2 group iia
12/24/2003WO2003105893A2 Probiotic therapies
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1272